newsfilter
← Latest News
GlobeNewswire·

Lucira Health Reports Pilot Study Interim Results for Chlamydia and Gonorrhea Assays

EMERYVILLE, Calif., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (NASDAQ:LHDX) ("Lucira Health" or "Lucira"), a medical technology company, today announced interim results of a pilot study to evaluate the performance of their combined Chlamyd